Swedish drugmaker Meda to explore sale of U.S. operations- Bloomberg
August 27, 2015 at 21:10 PM EDT
Aug 28 (Reuters) - Swedish drug maker Meda AB is exploring options to sell its U.S. subsidiary Meda Pharmaceuticals Inc, which could be worth about $1 billion, Bloomberg reported, citing people familiar with the matter.
